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Validity assessment of the PROMIS 
fatigue domain among people living with HIV
L. E. Gibbons1,10*, R. Fredericksen1, D. S. Batey2, L. Dant3, T. C. Edwards4, K. H. Mayer3,5, W. C. Mathews6, 
L. S. Morales7, M. J. Mugavero8, F. M. Yang9, E. Paez6, M. M. Kitahata1, D. L. Patrick4, H. M. Crane1, P. K. Crane1 
and for the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS)
Abstract 
Purpose: To evaluate psychometric characteristics and cross-sectional and longitudinal validity of the 7-item 
PROMIS® Fatigue Short Form and additional fatigue items among people living with HIV (PLWH) in a nationally distrib-
uted network of clinics collecting patient reported data at the time of routine clinical care.
Methods: Cross-sectional and longitudinal fatigue data were collected from September 2012 through April 2013 
across clinics participating in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS). We ana-
lyzed data regarding psychometric characteristics including simulated computerized adaptive testing and differential 
item functioning, and regarding associations with clinical characteristics.
Results: We analyzed data from 1597 PLWH. Fatigue was common in this cohort. Scores from the PROMIS® Fatigue 
Short Form and from the item bank had acceptable psychometric characteristics and strong evidence for validity, but 
neither performed better than shorter instruments already integrated in CNICS.
Conclusions: The PROMIS® Fatigue Item Bank is a valid approach to measuring fatigue in clinical care settings 
among PLWH, but in our analyses did not perform better than instruments associated with less respondent burden.
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Background
Fatigue is a common clinical symptom and adversely 
impacts health-related quality of life. Fatigue is highly 
prevalent among persons living with HIV (PLWH) [1, 2]. 
It is a common side-effect of antiretroviral medications 
[3], and it is associated with several adverse clinical out-
comes, including longer time until depression remission 
[4], poorer physical functioning [5, 6], poorer adherence 
to antiretroviral medications [7], and virologic failure [8]. 
Patients rank fatigue as an important domain for provid-
ers to know about in order to provide good care [9].
In many cases fatigue is not systematically assessed 
as part of clinical care. Challenges that impede fatigue 
assessment for research in PLWH have been outlined 
previously, including lack of consistent measurement, 
lack of longitudinal measurement, and lack of compre-
hensive clinical data to examine potential predictors of 
fatigue [10]. Measuring fatigue for clinical care further 
compounds these issues as there are substantial time 
constraints and logistical hurdles that must be addressed 
to minimize impact of assessment on clinical flow.
One option for assessing fatigue among PLWH is 
the HIV-Related Fatigue Scale [10–12]. This is a well-
designed measure with 56 items including subscales 
addressing concepts such as intensity and impact. Unfor-
tunately, it is too long to be useful in most routine clini-
cal care settings. At the opposite end of the spectrum are 
very brief assessments such as the single item included in 
the HIV symptoms index [13].
The Patient Reported Outcomes Measurement and 
Information System (PROMIS®, http://www.nihpromis.
org) is a National Institutes of Health Roadmap initia-
tive to develop item banks to measure patient-reported 
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symptoms. PROMIS investigators developed a fatigue 
item bank [14]. Items from the bank can be used as either 
a fixed-length short-form or as a computerized adap-
tive test (CAT) [15]. The PROMIS® Fatigue Item Bank 
was developed for people in general rather than specific 
patient groups such as PLWH, which facilitates com-
parisons with the general population and across patient 
groups [16]. Well-developed and calibrated universal 
fatigue measures could enhance comparability of findings 
and serve as a common metric of fatigue across condi-
tions [15]. Yet, previous analyses of the PROMIS® fatigue 
domain were not conducted among PLWH, and were 
not carried out in the context of routine clinical care. We 
conducted this study to better understand the properties 
of the PROMIS® fatigue instrument as part of routine 
clinical care for PLWH.
Methods
Study cohort
This study was conducted in the Centers for AIDS 
Research Network of Integrated Clinical Systems 
(CNICS) cohort [17], which integrates comprehensive 
inpatient and outpatient clinical data on PLWH in the 
cohort [17]. PLWH complete the CNICS clinical assess-
ment of patient reported measures, symptoms, and out-
comes (PROs) every 4–6 months as part of routine clinic 
visits [18, 19]. They use touch screen tablets or personal 
computers using web-based survey software developed 
specifically for PROs [18, 20] to complete the clinical 
assessment which includes a variety of measures such 
as the HIV Symptoms Index [13], the Patient Health 
Questionnaire (PHQ-9) [21, 22] for depression, and the 
modified Alcohol, Smoking, and Substance Involvement 
Screening Test [23, 24] for illicit drug use. The assess-
ment was integrated into clinical care for regularly sched-
uled clinic visits at each site. No exclusions were made on 
the basis of severe fatigue.
Study participants
PLWH 18 years old or older who spoke English or Span-
ish at four clinics (University of Washington Madison 
HIV Clinic, Seattle; University of Alabama at Birming-
ham 1917 Clinic, Birmingham; University of California 
San Diego HIV Clinic, San Diego; and Fenway Health, 
Boston) were eligible to participate in this study. Data 
were collected from 1597 PLWH from September 2012 
to April 2013.
Qualitative analyses
We conducted in-depth interviews in English and Span-
ish with 42 patients endorsing fatigue to elicit concepts 
regarding the experience of living with fatigue and HIV, 
as described elsewhere [25]. We excerpted and coded 
transcribed interview content using codes adapted from 
PROMIS® Fatigue Item Bank content. We matched coded 
interview content to bank items. The team assessed 
unmatched content for possible new item development. 
We reviewed all proposed items using PROMIS® Quali-
tative Item Review criteria [26], for readability using the 
Lexile Analyzer, and for translatability into English or 
Spanish. We held focus groups with 68 patients and asked 
them to rank-order the prospective item list in order of 
importance for their provider to know. We retained the 
most important items and conducted cognitive inter-
views with 21 patients to assess item comprehensibil-
ity, modifying items as needed [25]. We developed four 
new items in addition to those already in the PROMIS® 
Fatigue Item Bank [25].
Item administration
We administered the 7-item PROMIS® Fatigue Short 
Form [27], an additional 13 items selected from the 
PROMIS® Fatigue Item Bank (including four items 
excluded from the final bank and, thus, without 
PROMIS® item parameters), and our four new items (see 
Table  1). We modified response options for five exist-
ing PROMIS® items because of qualitative feedback. 
We used PROMIS® item parameters for all of the other 
PROMIS® items but calibrated the five items with new 
response options anew.
Quantitative analyses
We used Stata [28] for all analyses unless otherwise 
noted.
Dimensionality
We used structural equation modeling to determine 
whether the items were sufficiently unidimensional to 
use item response theory (IRT) in our sample. All struc-
tural equation models were fit in Mplus [29]. We applied 
the following thresholds for acceptable model fit: con-
firmatory fit index (CFI)  >  0.95, Tucker–Lewis index 
(TLI) > 0.95, and root mean squared error of approxima-
tion (RMSEA) < 0.08 [30].
PROMIS® item parameters
We performed additional analyses to determine whether 
it was appropriate to use PROMIS® item parameters 
in our population of PLWH. We initially fixed all seven 
items from the fatigue short form to their PROMIS® val-
ues and used modification indices to identify the item 
for which constraining parameters to PROMIS® values 
had the greatest impact on model fit. We then removed 
those constraints and freely estimated parameters for 
that item and identified the next item that had the great-
est impact on model fit. We repeated this procedure until 
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we were left with two anchor items. We extracted factor 
scores from the PROMIS®-fixed model and from a model 
with the final two anchor items and five freely estimated 
items and calculated correlations between these scores. 
We plotted agreement between scores using a variant 
of a Bland–Altman plot, with the difference between 
the scores on the y-axis and the PROMIS®-fixed model 
scores on the x-axis. We superimposed the standard 
error of measurement (SEM) curve on this graph and 
examined whether the differences were smaller than the 
SEM at each level of fatigue.
Comparison of measurement properties of scores
We computed an IRT score for all 24 items. We fixed item 
parameters for the 11 PROMIS® items with PROMIS® 
response options to their PROMIS® values, so scores are 
on the PROMIS® metric. We freely estimated parameters 
for the other 13 items. We compared the SEM for the 
PROMIS®-7a short form to that from all 24 items.
Simulated CAT
We used Firestar [31] to simulate CAT from the 24-item 
bank we administered. We categorized PLWH into groups 
based on PROMIS® fatigue scores:  <40, 40–50,  >50–60, 
and >60. We set the minimum number of items adminis-
tered by the simulated CAT at 7 and the default stopping 
rule of SEM  <  0.3 (equivalent: T-metric SEM  <  3). We 
determined the proportion of times each item was admin-
istered to people in each fatigue level group. We used 
seven items as a minimum to determine the extent of over-
lap between items selected by CAT and items included in 
the 7-item PROMIS® Fatigue Short Form. As a sensitivity 
analysis, we performed a second CAT simulation with no 
minimum number of items and used a 0.3 SEM or seven 
items maximum stopping rule. We compared patient bur-
den based on the average completion times per item for 
patients from one site (University of Washington) who 
completed both instruments, based on the 7-item short 
form and the number of items in the 2 CAT simulations.
Differential item functioning (DIF)
We used the Stata command—difwithpar—[32] to evalu-
ate items for DIF with respect to age, sex, race, and nadir 
CD4 count. We used a P value criterion of 0.05 for uni-
form and for non-uniform DIF. The—difwithpar—algo-
rithm uses demographic-specific item parameters for 
items identified with DIF and generates new scores that 
account for DIF. We evaluated DIF impact by comparing 
naïve scores that ignored DIF to those that accounted for 
DIF. We use differences of score larger than 0.3 points on 
the theta metric (larger than 3 points on the T metric) as 
the primary threshold to indicate salient DIF impact and 
the median SEM as a more stringent threshold.
Associations with clinical characteristics
We used Spearman correlations to compare cross-
sectional associations between clinical characteristics 
and the HIV Symptoms Index fatigue item [13], the 
“tired” item from the PHQ-9 [21, 22], the PROMIS®-7a 
score, and the score derived from the entire 24 items we 
Table 1 Fatigue items administered, with  a priori subdo-
mains
a Because different response options were offered in this study, we did not use 
the PROMIS item parameters for these items
Item description Subdomain
PROMIS 7-item Fatigue Short Form 
 How often did you feel tired? Experience
 How often did you run out of energy? Experience
 How often were you too tired to take a bath or shower? Impact
 How often did you experience extreme exhaustion? Experience
 How often did your fatigue limit you at work (including 
work at home)?
Impact
 How often were you too tired to think clearly? Impact
 How often did you have enough energy to exercise 
strenuously?
Impact
Other calibrated PROMIS items
 How often were you physically drained? Experience
 To what degree did you have to force yourself to get up 
and do things because of your fatigue?
Impact
 How run-down did you feel on average? Experience
 How fatigued were you on average? Experience
Items calibrated in PROMIS but administered with different response 
optionsa
 How fatigued were you when your fatigue was at its 
worst?
Experience
 To what degree did your fatigue interfere with your 
physical functioning?
Impact
 I felt fatigued Experience
 I had trouble starting things because I was tired Impact
 How much were you bothered by your fatigue on aver-
age?
Experience
Uncalibrated PROMIS items
 How often did you wake up feeling exhausted? Experience
 How often did you feel so exhausted that you stayed in 
bed all day?
Impact
 How often were you too exhausted to take your medica-
tion?
Impact
 How often were you so exhausted that you missed 
appointments?
Impact
New items from qualitative interviews
 How often were you too exhausted to carry out your 
daily responsibilities?
Impact
 How often did your body feel exhausted? Experience
 How often were you too exhausted to chew and swallow 
food?
Impact
 How often were you too exhausted to concentrate? Impact
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administered. The clinical characteristics included: hepa-
titis C virus co-infection; nadir and current CD4 count; 
the number of symptoms endorsed on the HIV Symp-
toms Index; specific symptoms endorsed on the HIV 
Symptoms Index; quality of life estimated using EQ-5D 
responses [33–36]; and the total PHQ-9 score. Among 
PLWH taking antiretroviral medications for HIV, we 
also determined associations between fatigue scores and 
medication adherence based on the last time the person 
stated they had missed medications, their self-reported 
ability to take medications, and the proportion of medi-
cations they were estimated to have taken [37–42].
Test–retest reliability
We had 51 people return to clinic on a second occa-
sion from 6–14 days following their initial assessment to 
repeat the assessment. Since this involved an extra visit 
outside the context of clinical care, we provided an incen-
tive of $15 for this activity. We used intraclass correlation 
coefficients (ICCs) to measure test–retest reliability.
Longitudinal evaluation
A subset of 249 PLWH had repeat assessment on a sec-
ond routine clinical care visit from 79–203 days following 
their initial assessment [median 119  days, interquartile 
range (IQR) 105–134 days]. Given the episodic nature of 
HIV symptoms [43], we were interested first in describing 
changes in fatigue. We also sought to compare changes in 
fatigue measures in two situations where change might 
be expected: concurrent with a change in depression 
symptoms or a change in methamphetamine use on the 
clinical assessment.
Results
Demographic and clinical characteristics from the 
cross‑sectional quantitative data
English questionnaires were completed by 1597 PLWH 
(Table  2); we included Spanish speakers in our qualitative 
analyses, but there were too few respondents in Spanish 
(n = 94) for meaningful quantitative analyses. Mean age (SD) 
was 45.7 (10.4), with a range from 20 to 83 (IQR 39, 53).
Fatigue was common in this cohort. Using the HIV 
Symptoms Index single item, 65% stated they had fatigue 
(Table  2). Scores from the PROMIS® items mapped 
closely to these scores from the HIV Symptoms Index. As 
shown in Fig. 1, median fatigue scores on the PROMIS® 
metric ranged from just below 40 for those who stated 
they did not have fatigue to just over 65 for those who 
stated they had fatigue and that it bothered them a lot.
Dimensionality
A single factor confirmatory factor analysis model did not 
fit well by RMSEA criteria (CFI 0.98, TLI 0.98, RMSEA 
0.103). We assigned items a priori to one of two subdo-
mains, the experience of fatigue vs. the impact of fatigue, 
based on PROMIS®’s domain framework (see Table  1), 
but this model did not fit well and had loadings that did 
not support the theoretical structure, such as negative 
loadings on a subdomain. A negative loading means that 
as levels of the item were of increasing severity, the level 
of fatigue impact was expected to be lower down, which is 
difficult to explain.
We then considered modification indices from a single 
factor model that suggested candidate pairs of items with 
residual correlations that would have the greatest impact 
on model fit. We included 6 such pairs, which resulted in 
a model with CFI 0.99, TLI 0.99, and RMSEA 0.08. We 
extracted factor scores for the single factor score and the 
bifactor score with the six residual correlations. These 
scores were highly correlated at 0.9999. We compared 
standardized factor loadings between these models, and 
the largest difference was 0.020, well lower than the 0.10 
threshold that would indicate a salient difference in load-
ings between the single factor and bifactor models [44]. 
These findings led us to conclude that the items were suf-
ficiently unidimensional to proceed with IRT analyses.
PROMIS item parameters
The loadings and thresholds for the two anchor items and 
the five freely estimated items are shown in Additional 
file  1. The correlation between the score using those 
parameters and the score based entirely on PROMIS 
parameters was  >0.99. All of the score differences were 
within the SEM curve thresholds (Additional file  2). 
These results supported use of PROMIS item parameters 
for PLWH.
Measurement properties
We show a plot of the SEM for the 24 items adminis-
tered and for the 7-item PROMIS® Fatigue Short Form 
subset in Fig. 2. The median SEM was 0.29 (range 0.24–
0.57; IQR 0.26–0.34) for the 7-item PROMIS® Fatigue 
Short Form and 0.15 (range 0.11–0.52; IQR 0.14–0.20) 
using all 24 items. On the T-score metric, the 7-item 
PROMIS® Fatigue Short Form has an SEM < 3 over the 
45–73 range, while using all 24 items gives an SEM under 
3 for all scores 35 and above. We also show a histogram 
of observed fatigue scores from the 7-item PROMIS® 
Fatigue Short Form on the same plot. There are very few 
people with extremely high levels of fatigue (over 73) for 
whom the 24 items would provide a markedly improved 
level of precision; most of the people for whom differ-
ences in precision between the 7-item short form and the 
24-item bank are characterized by low levels of fatigue, 
with scores 35-45 on the PROMIS® metric. While 
scores in this range are common, it may not be clinically 
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important to measure fatigue levels precisely in these 
individuals 1.5–2.5 SD below national norms for fatigue.
CAT results
Our first CAT simulation used a minimum of seven 
items. With this criterion, only people with PROMIS 
fatigue scores  <40 required more than seven items to 
achieve a SEM  <  3 on the T-metric (Table  3). There 
were two items that were administered in all simulated 
CATs: “How run-down did you feel on average” and “How 
fatigued were you on average.” The item “How often were 
you physically drained” was almost always administered. 
None of the items from the 7-item PROMIS® Fatigue 
Short Form was routinely selected for CAT administra-
tion across all fatigue levels, though “How often did you 
feel tired” and “How often did you run out of energy” 
were always administered to individuals with fatigue 
scores <40.
As outlined in our previous publication, we developed 
four new fatigue items based on our qualitative work 
[25]. In simulated CAT, one of these, “How often did your 
body feel exhausted?” was selected 46% of the time; it was 
always selected for people with fatigue scores ≤40, 61% 
of the time for fatigue scores >40–50 and 46% of the time 
for those with the highest levels of fatigue. In contrast, 
the other new items we developed were either never or 
rarely selected for people with fatigue levels  >40; these 
items were “How often were you too exhausted to carry 
out your daily responsibilities?”, “How often were you too 
exhausted to chew and swallow food?” and “How often 
were you too exhausted to concentrate?”
In our secondary analyses, we completed another 
CAT simulation with no minimum number of items and 
a stopping rule of either a standard error of measure-
ment <3 points on the T metric or up to 7 items maxi-
mum; the median (IQR) number of items administered 
was 3 (3–4).
Based on the mean time per item for the PROMIS 
fatigue items (mean 6.73  s, SD 2.74 per item), a person 
completing the 7-item PROMIS short form or 7-item 
CAT would be expected to take an average of 47.1  s. 
Based on the second simulated CAT where people com-
pleted a mean of 3 items, the average completion time for 
the PROMIS fatigue CAT would be 20.2 s. This is in com-
parison to an estimated time to complete the HIV Symp-
tom Index fatigue screening item of 6 s (mean 6.0 s, SD 
10.1).
DIF results
A few items had DIF with respect to age, sex, race, and/
or nadir CD4 count with the very sensitive DIF thresh-
olds we used (results not shown). There was negligi-
ble DIF impact, and for none of these covariates was 
there any individual PLWH where accounting for DIF 
Table 2 Participant characteristics (n = 1597)
Characteristic N Percent Recent CD4 <500 Recent CD4 500+
N Percent N Percent
Male 1315 82.3 591 84.8 724 80.4
Race
 White 861 53.9 346 49.6 515 57.2
 Black 461 28.9 197 28.3 264 29.3
 Hispanic 195 12.2 105 15.1 90 10.0
 Other 80 5.0 49 7.0 31 3.4
HIV Symptom Index fatigue item
 No fatigue 558 34.9 233 33.4 325 36.1
 Doesn’t bother me 151 9.5 66 9.5 85 9.4
 Bothers me a little 383 24.0 161 23.1 222 24.7
 Bothers me 260 16.3 117 16.8 143 15.9
 Bothers me a lot 221 13.8 110 15.8 111 12.3
 Did not answer 24 1.5 10 1.4 14 1.6
CD4 Nadir
 <200 732 45.8 487 69.9 245 27.2
 200 to <350 392 24.6 152 21.8 240 26.7
 350 or higher 468 29.3 55 7.9 413 45.9
 Missing 5 0.3 3 0.4 2 0.2
Taking anti-HIV meds 1412 88.4 604 86.7 808 89.8
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led to a change in score as much as three points on the 
PROMIS T-score metric. Indeed, when we considered a 
more stringent 1.7 points PROMIS T-score metric (the 
median SEM for this sample), only 1–7 people (all <1%) 
had DIF impact of this magnitude with respect to 
each of these covariates. We concluded that there was 
negligible DIF in these items with respect to these 
covariates.
Associations with clinical characteristics
The HIV Symptom Index single item fatigue score was 
closely associated with the 7-item PROMIS® Fatigue 
Short Form (ρ = 0.82) and with the score from all of 24 
items (ρ =  0.85) (Table  4). Similarly, the PHQ-9 fatigue 
item was closely associated with the HIV Symptoms 
Index fatigue item (ρ = 0.77), with the 7-item PROMIS® 
Fatigue Short Form (ρ  =  0.75), and with the 24-item 
score (ρ  =  0.77). Correlations with clinical characteris-
tics were generally as strong for the HIV Symptom Index 
fatigue item as they were for either the 7-item PROMIS® 
Fatigue Short Form or the full 24-item score.
Test–retest reliability
Fifty-one people completed the 7-item PROMIS® 
Fatigue Short Form again 6–14  days later (median 8, 
IQR 7–11 days). The ICC was 0.74 (0.55, 0.83). The mean 
change was −0.17 points, though 4 people had a decrease 
of at least on point and 2 had an increase of at least one 
point, either due to true changes in fatigue [43] or meas-
urement error. Among the 31 people who said their level 
of fatigue was “about the same” as previously, the ICC 
was similar at 0.66 (0.44, 0.81).
Longitudinal analyses
On average there was little change in level of fatigue over 
approximately 4  months—the mean change was −0.16. 
However, this obscures individual variation, in that 9% 
reported an increase in fatigue of at least one point, and 
16% reported a decrease of at least one point. Changes in 
the PHQ-9 depression score were more highly correlated 
with changes in the HIV Symptom Index fatigue item 
(Spearman ρ  =  0.47) than were changes in the 7-item 
PROMIS® Fatigue Short Form score (ρ = 0.39). Only 13 
people changed from using methamphetamines to not, 
or vice versa, so comparisons of the fatigue measures 
were not feasible.
30 40 50 60 70 80
PROMIS−7a
It bothers me a lot
It bothers me
It bothers me a little
It does not bother me
I do not have the symptom
a HIV Symptom Index Fatigue Item
30 40 50 60 70 80
PROMIS−7a
< 100
100 to < 200
200 to <350
350 or higher
b  Recent CD4 Count
30 40 50 60 70 80
PROMIS−7a
Yes
No
c  Hepatitis C
Fig. 1 Box and whisker plots showing the distribution of PROMIS® 
7a fatigue scores on the PROMIS® T score metric for each level of 
fatigue according to the HIV symptoms inventory fatigue item* (a); 
for people with different recent CD4+ T-cell counts (b), and with 
and without Hepatitis C virus co-infection (c). *For these plots, the 
box shows the 25th and 75th percentile scores, and the median is 
shown with a white vertical bar within the box. The whiskers show 1.5 
times the extent of the box. Dots show more extreme values. In a, the 
median score for the group who denied having fatigue was around 
40; the median for those who had fatigue but stated it did not bother 
them was around 45; the median score for those who had fatigue 
that bothered them a little was around 53; the median score for those 
who had fatigue that bothered them was around 58; and the median 
score for those who had fatigue that bothered them a lot was around 
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Fig. 2 Histogram of observed fatigue levels (open bars) superim-
posed on standard error of measurement curves for the 24 fatigue 
items administered to participants (lower light gray curve) and for 
the 7-item PROMIS® Fatigue Short Form (upper darker gray curve). A 
horizontal line is at a SEM of 3, which is the common default stopping 
rule for computerized adaptive testing
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Discussion
In a thorough evaluation of the psychometric properties 
of the 7-item PROMIS® Fatigue Short Form and addi-
tional items selected from the PROMIS® Fatigue Item 
Bank or items specifically developed for this project, 
we found that these fatigue items had excellent content 
validity among PLWH. While the 24 fatigue items did 
not form a scale that was strictly unidimensional, it was 
sufficiently unidimensional to use item response theory. 
Furthermore, our analyses suggested that PROMIS® item 
parameters were appropriate to use among PLWH. We 
used very sensitive DIF detection thresholds and identi-
fied items with DIF, but did not find salient impact for 
DIF with respect to age, sex, race, or nadir CD4 count. 
Scores from the 7-item PROMIS® Fatigue Short Form or 
from all 24 items from the fatigue item bank had excel-
lent validity in a variety of analyses, but were no better 
than the HIV Symptom Index single fatigue item meas-
ure or the fatigue item from the PHQ-9. The HIV Symp-
tom Index single fatigue item has limited ability to detect 
change over time, because it has only a few response 
options. Nevertheless, in the longitudinal sample, we did 
Table 3 Frequency of item administration in simulated computerized adaptive testing, by level of fatigue
Item Overall (n = 1597) Fatigue score
≤40 (n = 246) >40–50 (n = 561) >50–60 (n = 556) >60 (n = 234)
How often did you feel tired? 22.0 100.0 18.4 0.0 1.3
How often did you run out of energy? 57.5 100.0 54.2 45.9 48.7
How often were you too tired to take a bath or 
shower?
6.6 43.1 0.0 0.0 0.0
How often did you experience extreme exhaustion? 7.3 45.9 0.0 0.0 1.7
How often did your fatigue limit you at work (includ-
ing work at home)?
8.9 57.7 0.0 0.0 0.0
How often were you too tired to think clearly? 7.8 45.9 0.0 0.0 4.7
How often did you have enough energy to exercise 
strenuously?
8.7 56.5 0.0 0.0 0.0
How often were you physically drained? 99.7 100.0 100.0 100.0 97.9
To what degree did you have to force yourself to get 
up and do things?
79.8 46.7 69.5 100.0 91.5
How run-down did you feel on average? 100.0 100.0 100.0 100.0 100.0
How fatigued were you on average? 100.0 100.0 100.0 100.0 100.0
How fatigued were you when your fatigue was at its 
worst?
11.6 75.2 0.0 0.0 0.0
To what degree did your fatigue interfere with your 
physical functioning?
70.6 49.6 38.3 100.0 100.0
I felt fatigued 47.3 64.2 82.7 22.1 4.3
I had trouble starting things because I was tired 20.5 48.0 0.0 35.1 6.0
How much were you bothered by your fatigue on 
average?
85.2 85.4 75.6 89.9 97.0
How often did you wake up feeling exhausted? 7.6 49.2 0.0 0.0 0.0
How often did you feel so exhausted that you stayed 
in bed all day?
6.9 44.7 0.0 0.0 0.0
How often were you too exhausted to take your 
medication?
6.2 40.2 0.0 0.0 0.0
How often were you so exhausted that you missed 
appointments?
6.6 42.7 0.0 0.0 0.0
How often were you too exhausted to carry out your 
daily responsibilities?
7.0 43.9 0.0 0.0 1.7
How often did your body feel exhausted? 46.1 100.0 61.3 7.0 46.2
How often were you too exhausted to chew and 
swallow food?
6.1 39.8 0.0 0.0 0.0
How often were you too exhausted to concentrate? 7.0 45.5 0.0 0.0 0.0
Mean number of items 8.3 15.2 7.0 7.0 7.0
Mean standard error of measurement (T-metric) 2.2 3.2 2.1 2.0 2.1
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not find evidence that the PROMIS scores were more 
responsive to change than was the HIV Symptom Index 
fatigue item or the PHQ-9 fatigue item.
Fatigue is clearly a relevant consideration for this clini-
cal population. Sizable numbers of PLWH had substantial 
levels of fatigue. One advantage of the PROMIS® fatigue 
metric is that we can relate fatigue levels to national aver-
ages. As shown in Fig. 1 and in Table 3, substantial num-
bers of PLWH endorse high levels of fatigue. Those who 
stated that they have fatigue that bothers them a lot on 
the HIV Symptom Index have median (IQR) PROMIS® 
fatigue scores of 66 (IQR 61–71), which is about 1.5 SD 
(1–2 SD) above the national average.
Our CAT simulations showed a small amount of over-
lap with the 7-item PROMIS® Fatigue Short Form. We 
set up the first simulation such that each individual 
received at least seven items to facilitate comparisons 
with the short form. Only people with very low fatigue 
levels received more than 7 items from the simulated 
CAT; everyone else received exactly 7 items. While the 
7-item short form may not include the most informa-
tive items from the PROMIS® Fatigue Item Bank, it 
nevertheless had good measurement precision across a 
broad range of fatigue levels (see Fig.  2). Furthermore, 
the 7-item PROMIS® Fatigue Short Form performed 
well in all of our validity analyses; indeed, scores from 
Table 4 Spearman correlation coefficients between fatigue measures and clinical characteristics
HIVSI fatigue PHQ‑9 “tired” PROMIS‑7a All 24 items
Coefficient P value Coefficient P value Coefficient P value Coefficient P value
Factors related to fatigue itself
 HIV Symptom Index 1-item Fatigue response – – 0.77 <0.0001 0.82 <0.0001 0.85 <0.0001
 PHQ-9 item “feeling tired or having little energy” – – – – 0.75 <0.0001 0.77 <0.0001
 Hepatitis-C 0.09 0.0004 0.09 0.0002 0.11 <0.0001 0.12 <0.0001
HIV disease severity
 Current CD4 count −0.04 0.1402 −0.04 0.1562 −0.05 0.0699 −0.04 0.2392
 CD4 nadir 0.01 0.8828 0.05 0.0534 0.00 0.8584 0.01 0.3481
Symptom burden
 Number of symptoms in inventory 0.69 <0.0001 0.59 <0.0001 0.64 <0.0001 0.66 <0.0001
Specific symptoms
 Fever, chills or sweats 0.42 <0.0001 0.37 <0.0001 0.64 <0.0001 0.44 <0.0001
 Dizzy or lightheaded 0.51 <0.0001 0.46 <0.0001 0.42 <0.0001 0.54 <0.0001
 Pain/numbness/tingling in hands/feet 0.44 <0.0001 0.35 <0.0001 0.52 <0.0001 0.49 <0.0001
 Having difficulty remembering 0.57 <0.0001 0.48 <0.0001 0.46 <0.0001 0.62 <0.0001
 Nausea or vomiting 0.45 <0.0001 0.37 <0.0001 0.63 <0.0001 0.47 <0.0001
 Diarrhea or loose bowel movements 0.41 <0.0001 0.34 <0.0001 0.47 <0.0001 0.42 <0.0001
 Feeling sad or depressed 0.65 <0.0001 0.55 <0.0001 0.40 <0.0001 0.66 <0.0001
 Feeling nervous or anxious 0.57 <0.0001 0.50 <0.0001 0.63 <0.0001 0.61 <0.0001
 Difficulty falling or staying asleep 0.57 <0.0001 0.50 <0.0001 0.58 <0.0001 0.59 <0.0001
 Coughing or trouble catching breath 0.39 <0.0001 0.36 <0.0001 0.56 <0.0001 0.44 <0.0001
 Headaches 0.42 <0.0001 0.35 <0.0001 0.43 <0.0001 0.46 <0.0001
 Appetite loss/change taste of food 0.45 <0.0001 0.43 <0.0001 0.44 <0.0001 0.52 <0.0001
 Bloating pains or gas in stomach 0.44 <0.0001 0.37 <0.0001 0.51 <0.0001 0.47 <0.0001
 Muscle aches or joint pain 0.47 <0.0001 0.42 <0.0001 0.47 <0.0001 0.52 <0.0001
 Sex-loss of interest/satisfaction 0.47 <0.0001 0.41 <0.0001 0.50 <0.0001 0.50 <0.0001
 Body changes-fat deposits/wt gain 0.46 <0.0001 0.38 <0.0001 0.50 <0.0001 0.49 <0.0001
 Weight loss or wasting 0.32 <0.0001 0.30 <0.0001 0.49 <0.0001 0.39 <0.0001
EQ-5D 0.59 <0.0001 0.56 <0.0001 0.38 <0.0001 0.64 <0.0001
PHQ-9 0.75 <0.0001 0.84 <0.0001 0.63 <0.0001 0.77 <0.0001
Self-rated health (EuroQOL) −0.53 <0.0001 0.50 <0.0001 0.74 <0.0001 −0.57 <0.0001
Among ART users
 Last time missed meds −0.15 <0.0001 −0.16 <0.0001 −0.18 <0.0001 −0.19 <0.0001
 Ability to take meds −0.19 <0.0001 −0.24 <0.0001 −0.23 <0.0001 −0.23 <0.0001
 Take how much of meds −0.14 0.0001 −0.16 <0.0001 −0.17 <0.0001 −0.17 <0.0001
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the 7-item PROMIS® Fatigue Short Form performed 
just as well as scores from the entire 24 items we consid-
ered. At the same time, briefer instruments, including the 
fatigue item from the PHQ-9 and the single HIV Symp-
tom Index fatigue item, also did well in all of our validity 
analyses. We did not find a compelling case to choose the 
PROMIS® fatigue scores over much shorter instruments. 
A CAT with different specifications could have arrived at 
a PROMIS fatigue score in fewer items, but it would be 
unlikely to have better performance in our validity analy-
ses than the entire scale considered here. Furthermore, 
the HIV Symptom Index fatigue item required much less 
time on average for patients to complete than the 7-item 
PROMIS short form, CAT, or even the shorter CAT 
with an average of 3 items. While this may be of limited 
importance in research settings, minimizing patient bur-
den in clinical care settings is important to avoid impact-
ing clinical flow.
Our findings should be considered in the context of 
strengths and limitations. Our study was performed in 
CNICS, which is a nationally distributed cohort of PLWH 
who are in clinical care. Our data were collected from 
convenience samples of PLWH seen in particular calen-
dar months, and were not purposefully sampled from 
people particularly likely to have changing fatigue levels. 
Generalizability is limited as our study was conducted 
only among PLWH. We did administer the PROMIS 
fatigue items to Spanish speakers, but had too few of 
them during the data collection window to facilitate anal-
yses of DIF. We found no evidence of DIF with respect 
to four covariates, but were not able to evaluate DIF with 
respect to Spanish vs. English. The CNICS assessment 
of patient-reported measures now includes Amharic, 
but unfortunately, an Amharic version of the PROMIS 
Fatigue Item Bank has not been developed, nor were we 
able to assess the performance of these items in any other 
language.
Our ability to evaluate change in fatigue over time was 
limited, because we had few options for external com-
parison. One validation option was changes in depression 
levels as measured by the PHQ-9, where we found that 
the HIV Symptom Index fatigue item was more closely 
correlated to changes in depression levels than were 
PROMIS scores. In theory, IRT scores are more accu-
rate measures of change over time than ordinal scales, 
because they have linear measurement properties [45], 
which means that one point of change in a score corre-
sponds to the same amount of change in fatigue regard-
less of the initial level of fatigue. Indeed, PROMIS® 
scores may have shown better responsiveness to change 
than the HIV symptoms index fatigue item scores had we 
designed our study specifically to collect data on people 
expected to change [46]. In that setting, a brief CAT may 
prove to have better responsiveness to change than the 
single HIV symptoms index fatigue item and may fit in a 
reasonable time footprint, making this a feasible choice in 
routine clinical care settings. Firmer conclusions regard-
ing responsiveness of PROMIS® scores among PLWH 
will require additional data.
This study has several strengths that are also worth 
noting. It includes a particularly relevant population 
(PLWH) given the high rates of fatigue experienced by a 
substantial proportion of this group. We studied the per-
formance of these items in a geographically and racially/
ethnically diverse population. We performed a variety of 
psychometric analyses using state-of-the-art approaches.
Fatigue in PLWH often does not remit [10], suggest-
ing the need for additional research to better understand 
factors leading to fatigue in PLWH and interventions to 
successfully address it. Research on fatigue among PLWH 
will require a sustainable systematic approach to measur-
ing fatigue in clinical care.
Conclusions
The PROMIS® Fatigue Short Form and other fatigue 
items performed well among PLWH, though we did not 
find evidence that they performed better than shorter 
legacy scales in the specific context of routine clinical 
care. Unless comparison to national norms is needed, 
the HIV Symptom Index fatigue item may be preferred in 
HIV clinical care settings due to reduced patient burden.
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